Lates News

In the early trading session, Hong Kong-listed biopharmaceutical stocks rose. Kangmei Bioengineering surged over 8%, Techpool Pharmaceuticals rose over 4%, BeiGene and Hutchison China MediTech both increased by nearly 4%, and Kingsure Biotechnology rose over 3%.